Abstract
Activation of the maternal immune system during gestation has been associated with an increased risk for neurodevelopmental disorders in the offspring, particularly schizophrenia and autism spectrum disorder. Microglia, the tissue-resident macrophages of the central nervous system, are implicated as potential mediators of this increased risk. Early in development, microglia start populating the embryonic central nervous system and in addition to their traditional role as immune responders under homeostatic conditions, microglia are also intricately involved in various early neurodevelopmental processes. The timing of immune activation may interfere with microglia functioning during early neurodevelopment, potentially leading to long-term consequences in postnatal life. In this review we will discuss the involvement of microglia in brain development during the prenatal and early postnatal stages of life, while also examining the effects of maternal immune activation on microglia and neurodevelopmental processes. Additionally, we discuss recent single cell RNA-sequencing studies focusing on microglia during prenatal development, and hypothesize how early life microglial priming, potentially through epigenetic reprogramming, may be related to neurodevelopmental disorders.
Similar content being viewed by others
Avoid common mistakes on your manuscript.
Introduction
Immune activation and neurodevelopment
The immune system plays an essential role during early development of the central nervous system (CNS). Maternal infection and activation of the maternal immune system have been associated with an increased risk for neurodevelopmental disorders (NDDs) in the still developing fetus [1]. In particular, autism spectrum disorder (ASD) [2] and schizophrenia (SCZ) [3, 4] are correlated to maternal immune activation (MIA) during pregnancy. The current evidence suggests that it is the maternal immune response towards a pathogen that can impact the developing brain and drives the increased risk for NDDs, and that the risk for NDDs is not pathogen-specific. Epidemiological data demonstrate how a range of pathogens triggering a MIA response are associated with an increased risk of NDDs in offspring [5], and this increased risk is not only limited to maternal infections. Other maternal immune stressors such as active atopic diseases like asthma [6] and auto-immune disorders [7] have also been associated with dysregulation of the immune system and an increased risk for NDDs in human offspring [8]. The development and manifestation of NDDs seems to be related to the timing of MIA, as evidenced by clinical and pre-clinical studies [9, 10]. Furthermore, animal studies demonstrate how administration of pro-inflammatory cytokines, specifically IL-6 or IL-17, are sufficient to cause NDD-like phenotypes in offspring, and conversely blocking cytokines during MIA induction can ameliorate these phenotypes [11, 12]. The ‘maternal immune activation hypothesis’ proposes that perturbations in immune interactions in utero during critical time frames of fetal development can drive neurodevelopmental disorders (NDDs).
Microglia: the main tissue-resident macrophages of the CNS
Microglia, the tissue-resident macrophages of the CNS, are considered a prime candidate for driving the increased risk of NDDs following immune activation during fetal development. As sentinels of the CNS, microglia continuously surveil their immediate surroundings through a combination of highly motile processes and an extensive repertoire of receptors collectively referred to as the microglial 'sensome’ [13,14,15]. In addition, microglia are able to rapidly react and adjust their phenotype accordingly [16, 17]. This enables microglia to act as immune responders to infection or injury and help maintain CNS homeostasis, fulfilling their primary physiological roles in the brain. When CNS homeostasis is compromised, microglia can respond by phagocytosing damaged neurons or aggregates and initiate an inflammatory response, thereby serving a neuroprotective role [18]. In the developing brain, microglia are also involved in various neurodevelopmental processes, including phagocytosing neural progenitor cells [19,20,21], guiding dopaminergic axonal extension, interneuron positioning [22], maintaining structural integrity, and selective pruning of supernumerary synapses [23,24,25] (Fig. 1). Disturbing microglial functioning during brain development can result in perturbations in the aforementioned processes.
Recent evidence suggest that already during early fetal development, microglia start to acquire a transcriptomic signature that resembles the adult microglia population marked by the increased expression of environmental- and immune sensing receptors [27]. An important implication of this is that microglia possibly already acquire their mature immune sensing properties at early fetal developmental stages, likely making them sensitive to immune activation during critical moments of fetal development. Indeed, a growing body of evidence consisting mostly of animal studies demonstrates that MIA can evoke a microglial response in the developing fetal brain. In parallel to the activation of microglia, MIA also results in neuropathological- and behavioural hallmarks resembling aspects of NDDs [28, 29]. Interestingly, microglia emerge in the brain early in development, before peak cortical neurogenesis and neuronal migration, and prior to the emergence of other glial cells, astrocytes and oligodendrocytes [30, 31]. So on top of their role as the primary immune responders of the CNS, they also uniquely inhabit the fetal brain during a key developmental time frame. Seeing how a growing body of evidence suggest that microglia are intricately involved in early neurodevelopmental processes, the timing of MIA might perturb microglial functioning and disrupt proper neural circuit formation thereby driving the increased risk for NDDs in the offspring.
In this review, we will discuss the physiological role of microglia in prenatal and early postnatal neurodevelopment, and examine the experimental evidence on the impact of MIA on microglia in relation to these neurodevelopmental processes. Additionally, we highlight the findings of recent scRNA-seq studies aimed at studying microglial heterogeneity during prenatal development, and hypothesize how the development of a MIA-induced innate immune memory, potentially governed by epigenetic reprogramming, might be linked to neurodevelopmental disorders.
The physiological role of microglia during early neurodevelopment
Microglial origins
Microglial cells have a unique ontogeny compared to the other major CNS cell types which derive from the neuroepithelial cells forming the wall of the neural tube. Instead, microglia originate in the yolk sac deriving from haemopoietic precursors and will colonize the developing CNS in distinct waves, prior to the closure of the blood–brain barrier [32]. The expression and activation of colony stimulating factor 1 receptor (CSF1R) is essential for the differentiation and development of the microglial cell lineage [32], and, in humans, loss of CSF1R due to a homozygous mutation can lead to a complete absence of microglia and structural brain malformations, epilepsy and neurodevelopmental regression [33]. In mice, primitive microglia start populating the developing CNS at embryonic day 9.5 (E9.5) [32], and this is observed at 4.5 gestational weeks (GWs) in humans [34, 35]. The emergence of microglial cells is commonly defined by the expression of ionized calcium binding adaptor molecule 1 (IBA1) in myeloid cells. Transmembrane protein 119 (TMEM119) can also be used to identify microglial cells, however, TMEM119 only stains a subset of homeostatic microglia. Microglia display a heterogenous pattern of colonization and distribution during development [36]. In the cortex, IBA1 + microglia have an initial increase in proliferation around 6 GWs, followed by a massive first wave of proliferative expansion peaking at 8 GWs [35]. Next, the expanded microglial cell pool shrinks through apoptosis, followed by a second less significant wave of proliferative expansion at 16 GWs until cell density drops again and reaches an equilibrium around 28 GWs [35]. Eventually, microglia will form a self-sustaining tissue resident macrophage population and act as the first responders to pathogenic intruders and tissue damage, thereby help in maintaining CNS homeostasis [37]. Notably, microglia already start populating the human embryonic CNS preceding peak neurogenesis and prior to the emergence of other glial cells, astrocytes and oligodendrocyte lineage cells [30, 31](Fig. 1). Moreover, in the developing embryonic cortex, microglia preferentially localize at sites important for neurogenesis [14, 20], hinting at microglial involvement in early neurodevelopment.
Microglia and prenatal neurodevelopment
Microglia are regulators of neurogenesis in the prenatal brain (Fig. 1). Early in the developing cortex, neural progenitor cells (NPCs) in the ventricular zone (VZ) and subventricular zone (SVZ) are proliferating and differentiating into radial glial cells. Radial glia asymmetrically divide into neuronal cells while also serving as scaffolding for newly formed maturing neurons to radially migrate to their correct cortical layers [38]. Only later in development, around 20 GWs in humans, radial glia begin producing the other CNS resident glial cells, astrocytes and oligodendrocytes [30, 31]. Both human and animal studies demonstrate how microglia are attracted and localized to sites of enhanced neurogenesis during early fetal neurodevelopment, in particular the cortical proliferative zones (the ventricular zone (VZ) and subventricular zone (SVZ)) [19,20,21]. Microglia migrate to sites of dead- or dying cells and can be directed through the expression of chemokines (CXCL12) by cortical progenitors [19]. Microglia have been shown to guide normal brain development through their phagocytosis of dead or dying cells [39], a feature seen in both the prenatal and adult CNS [40]. Notably, at these highly neurogenic sites of the VZ/SVZ, microglia closely interact with and phagocytose neural precursor cells (NPCs) which do not all necessarily undergo apoptosis [20, 41]. Thus, microglia can actively deplete viable NPCs through selective processes other than the apoptotic pathway and regulate the pool of NPCs. Additionally, early in the postnatal brain (P3), microglia have been demonstrated to promote neural cell death [42], and modulating an increase or decrease in microglial activation was able to decrease or increase the NPC pool, respectively [20]. Conversely, microglia can also promote the migration and differentiation of NPCs [43, 44], and in the early postnatal brain of rats it was found that microglia can promote proliferation of neuronal and oligodendrocyte progenitors, possibly through the release of inflammatory cytokines [45].
Microglia also guide axonal tract organization and positioning of interneurons. During development, microglia closely associate with dopaminergic axonal tracts in the cortex, and perturbing microglial functioning through immune activation resulted in reduced extension of dopaminergic axons and the positioning of interneuron populations, including parvalbumin (PV) expressing interneurons [22]. This is particularly interesting, since dysfunction of the dopaminergic and PV interneuron circuits have both been strongly implicated in neurodevelopmental disorders such as SCZ [46]. Additionally, microglia associate with the corpus callosum, a structure consisting of organized axonal bundles connecting the left and right brain hemisphere [47]. Perturbing microglial functioning resulted in disorganization of the dorsal callosal axons [47]. scRNA-seq data identified a specific subcluster of microglia, seemingly in an activated state based on their transcriptional and morphological signature, that tightly associate with the subcortical axon tracts of the corpus callosum and the cerebellum in the early postnatal brains of mice [48]. A similar subpopulation of microglia was identified in the rodent and human prenatal brain that tightly localize to sites bordering the cortex undergoing morphogenetic stress, following the natural progression of prenatal brain development [26]. Transiently depleting microglia in mice results in cavitary lesions at these sites, suggesting a protective role of microglia maintaining the integrity of CNS structures undergoing morphogenetic stress [26]. In summary, experimental evidence demonstrates that during the critical window of prenatal CNS development, microglia are involved in early neurodevelopmental processes, including neurogenesis, dopaminergic axonal extension, interneuron positioning, maintaining CNS structural integrity, and disturbing microglial functioning can disrupt these processes.
Microglia and early postnatal neurodevelopment
Microglia continue to support neurogenesis and neural circuit maturation in the postnatal brain. In the hippocampus, microglia engulf and phagocytose apoptotic neurons while not necessarily being in an activated state [49]. Microglia also phagocytose oligodendrocyte progenitor cells (OPCs) and pre-myelinating oligodendrocytes [50], and a subset of CD11c + microglia play a role in oligodendrocyte maturation and myelination in the early postnatal brain [51]. Furthermore, microglia start specialising in regulating synaptic densities. In the developing brain, there is an initial overproduction of synapses, followed by the elimination of excess and weak synapses, which continues until adolescence. This process is essential for the refinement of neural circuits and cognitive development. In their resting state, microglia frequently contact nearby synapses in an activity-dependent manner [52, 53] and can remodel synaptic connections accordingly [24]. Early in postnatal development during peak synaptogenesis, microglia actively engulf and eliminate synapses, a process called ‘synaptic pruning’ [23]. Microglia selectively prune synapses of less active neurons [24, 25], thereby microglia are likely assisting in the remodelling for efficient neural connectivity. In mice, it was demonstrated that microglial depletion in the early postnatal period (P4) results in a temporary increase in synaptic connections from both excitatory and inhibitory neurons, including PV + and somatostatin + interneurons, projecting unto excitatory neurons [54]. A subpopulation of GABA-responsive microglia was found to remodel inhibitory circuits by preferentially engulfing and pruning inhibitory synapses [54]. Inhibiting microglial-neural interactions by knocking out either the neuronally expressed fractalkine (CX3CL1), or the fractalkine receptor (CX3CR1) primarily expressed by microglia results in inhibition of synaptic elimination on neurons downstream after sensory lesioning [25]. Additionally, deletion of CX3CR1 in mice resulted in a transient increase in synaptic density and a delay in neural circuit maturation [23]. The exact mechanism underlying microglial-dependent synaptic elimination is not completely understood. In mice, it was demonstrated that synaptic pruning during CNS development is also dependent on astrocyte-microglial interactions through cytokine signalling, indicating that other glial cells are also involved in regulating synaptic density [55]. Moreover, while studies conclude how microglia completely engulf and phagocytose synaptic material [23], a form of incomplete engulfment called ‘trogocytosis’-or nibbling- has also been described leading to the elimination of pre-synaptic material [56]. On the other hand, microglia can also promote the formation of dendritic spines in the early postnatal brain [57] and during learning-dependent remodelling of dendritic spines in mice [58]. Overall, microglia play an active role in the formation and maturation of functional synaptic connectivity during development.
Microglial heterogeneity throughout prenatal neurodevelopment from a scRNA-seq perspective
Recently, the advancement of single cell techniques has allowed for unbiased analysis of the transcriptomic changes in microglia during development. Using scRNA-seq, it was demonstrated that during normal development, human fetal microglia initially form a highly heterogeneous pool of cells compared to the adult population [27]. Moreover, human [27, 59] and animal [48, 60] scRNA-seq studies demonstrate how distinct microglial transcriptomic phenotypes are observed at specific moments and brain regions during fetal development. This suggests that in early life, unique subpopulations of microglia acquire specialised transcriptomic profiles likely associated with functional consequences, coordinated by their spatial–temporal context. A set of microglial clusters can be identified enriched in neuronal markers, consistent with the physiological role of microglia phagocytosing neuronal cells and synapses [27, 59]. A set of ‘immune-enriched’ microglial clusters can also be found, marked by the increased expression of genes related to inflammation [27, 59]. The neuronal-enriched clusters were found to become region-specific and predominantly emerged from 8–18 GWs [59]. Clusters of immune-enriched microglia, were found throughout the fetal brain, as well as region specific clusters arising only in later stages of development [27, 59]. On the other hand, clusters of microglia enriched in proliferation markers can be found throughout development, displaying no region-specific distributions, seemingly indicative of their collective proliferative potential [59]. The functional significance of the individual clusters is not yet clear. A striking finding across the single-cell studies focusing on fetal microglia, is the increased expression of genes associated with ‘disease associated microglia’ (DAM), including CD11c, SPP1, APOC1, APOE, CLEC7A, and GPNMB [27, 59, 61]. This suggests that in the context of neurodegenerative disease, the early developmental microglial transcriptomic programming is rekindled [62]. In mice, microglial subsets have previously been described closely associating with axonal tracts of the corpus callosum and proliferating areas coined ‘axonal tract-associated microglia (ATM)’ [63] and ‘proliferation-associated microglia (PAM)’ [64], respectively, which share a DAM-like signature. Disturbing microglial functioning was found to result in the disorganization of axonal bundles in the corpus callosum [47]. ATM were originally identified in the early postnatal brain of mice but ATM-like cells are now also found accumulating at specific sites bordering the cortex, both in the prenatal rodent and human CNS [26]. Transiently deleting microglia resulted in cavitary lesions specifically at these undergoing morphogenetic stress, suggestive of their role in maintaining structural integrity [26]. These results indicate that microglial subtypes sharing a DAM phenotype have a reactive phenotype and are involved in specific neurodevelopmental processes. Still, the functional significance of DAM-like phenotypes during early development is not yet clear, and the transient emergence of DAM-like cells in various contexts might indicate a generalized microglial response towards different environmental stimuli [65].
Progressively during fetal development, microglia start to acquire a more homeostatic and homogenous transcriptomic signature that is characterized by the expression of environmental- and immune-sensing receptors and bear more resemblance to the adult microglial population [27]. Notably, in humans already at early fetal developmental stages (GW12-13) microglia start to acquire mature immune sensing properties, possibly making them more susceptible to immune activation. The microglial transcriptome going from a heterogenous, proliferative phenotype to a more homogenous, homeostatic and immune-sensing phenotype during development is also seen in mice, though the timing is different compared to humans [63, 66, 67]. A recent scRNA-seq paper in mice, demonstrated that MIA initially leads to transcriptomic changes in fetal microglia, including the differential expression of genes related to proliferation and immune activation [68]. There were no changes in the proportions of clusters or the identification of unique clusters shortly after stimulation and in juveniles (P14) [68]. However, they did find a small subset of genes differentially expressed across all microglial clusters, and remained differentially expressed in juveniles [68]. In mice, MIA exposure causes the fetal microglial transcriptome to become more similar to the adult population [66]. This indicates that immune activation causes microglia to progress earlier to their more mature, immune-reactive phenotype [66]. The observation of accelerated microglial transcriptional maturation following immune stimulation is also seen when adolescent mice are challenged, specifically in males [67]. Potentially, the timing of the MIA-induced shift in microglial molecular machinery to a more ‘advanced’ phenotype during prental neurodevelopment might disrupt early microglial functioning and cause disruptions in the still developing CNS. In line with this thesis, scRNA-seq of human fetal CNS tissue revealed a population of ‘immune-related microglia’ which spontaneously exited their initially acquired resting status at GW23 through the downregulation of homeostatic genes (TMEM119, P2RY12/13, and CX3CR1) and upregulated expression of CD68 [59]. Perhaps, this switch in immune phenotype follows the natural step-wise maturation process of microglia, and immune activation through external stimuli perturbs this step-wise maturation process and, consequently, disrupts microglial functioning. The transition from a homeostatic to an active transcriptomic signature is conserved in mice; however, in mice, this transition occurs early postnatal life (P2), highlighting a difference in microglial development between humans and mice [59]. However, this is still consistent considering that the neurodevelopmental processes happening predominantly during late gestation in humans continue through the postnatal period in rodents [69].
One study identified a rare population of CD4 + T cells in the mouse and human brain, and found that presence of the CD4 + T cell population was required for immature and developing microglia to complete their fetal-to-adult transcriptional maturation in mice [70], showcasing a potential role for the peripheral immune system in microglial development. The immature transcriptional profile of microglia showed a relatively lower expression of genes involved in synaptic pruning and was found alongside increased synaptic densities of cortical pyramidal neurons, implicating perturbations in microglial functioning and pruning [70]. Microglial crosstalk with T cells has mainly been studied in the context of neuropathological conditions, but seeing the involvement of the peripheral immune system in microglial development warrants further investigation, despite the scarcity of peripheral immune cells in the normal developing brain.
The effect of MIA on microglia and neurodevelopment
Emerging evidence demonstrates how microglial-neural crosstalk is intricately involved in shaping the complex CNS cytoarchitecture by guiding neurogenesis, neural wiring and synaptic remodelling early in development. Possibly, by perturbing microglial-neural crosstalk through exposing immune sensitive microglia to MIA during the critical timeframe of fetal neurodevelopment can disrupt early neurodevelopment, and drive the increased risk for NDDs.
Animal models of MIA recapitulate aspects of NDDs
Animal models of MIA recapitulate behavioural- and neuropathological aspects seen in NDDs, thereby providing an invaluable tool to study the effects of MIA on neurodevelopment. Commonly, these animal models of MIA use injections of either i) a synthetic analogue of double-stranded RNA (Poly I:C) or ii) a component of the bacterial cell wall called lipopolysaccharide (LPS) to elicit an immune response [71]. Poly I:C is recognized by toll-like receptor 3, member of a class of transmembrane proteins with a role in innate immunity whereas LPS is mainly recognized by toll-like receptor 4 [71]. In animal models, MIA results in repetitive behaviour and abnormal social interactions corresponding to ASD-like behaviour [28]. Furthermore, MIA induction results in behavioural alterations mimicking aspects characteristic of SCZ, including increased locomotor activity upon stimulation with amphetamine, as well as deficits in sensorimotor gating [28]. Several structural and functional brain alterations are observed in the brain following MIA including changes in dopaminergic circuits which is a neuropathological hallmark strongly associated with SCZ in humans [28, 29]. In line with clinical data, the timing of MIA in animal models seems to be an important determinant in the manifestation of the behavioural and neuropathological phenotype seen in the offspring [72]. We can also draw parallels with clinical observations of sex-specific differences in NDD manifestation and the behavioural and neuropathological phenotypes in animal studies [73].
The effect of MIA on microglial density and ‘activation’
Numerous animal studies have described changes in microglial cell number and increased microglial ‘activation’ in offspring following MIA exposure, however these findings are contrasted by studies reporting no change in microglial density or activation [28]. Likely, these inconsistencies are the result of methodological differences, such as strategies for inducing MIA (i.e., LPS or Poly I:C; timing and dosing of MIA), readout of microglial ‘activation’ markers, and the timing of readouts [74]. It is also important to consider the complex microglial heterogeneity in their spatio-temporal context, especially during early neurodevelopment as highlighted by scRNA-seq studies on fetal CNS tissue [27, 59, 63, 66]. Microglial density and single activation markers cannot capture the complete spectrum of microglial ‘activation’ states and functional responses. The sum of these factors makes it difficult to compare and interpret the literature studying the effect of MIA and microglial involvement. Nevertheless, numerous studies support that fetal microglia are activated and respond to MIA, and this is backed up by studies noting an increase in the microglial gene expression of pro-inflammatory cytokines following MIA [75,76,77]. Furthermore, MIA induced changes in the microglial transcriptome and phagocytic function have been observed in adult microglia [78].
MIA-induced effects on the neuronal level
MIA leads to microglial activation, disrupts the transcriptome of cortical neuronal cell types, and leads to perturbations in neurogenesis and interneuron dysfunction. MIA induction in mice causes lasting changes in the transcriptomic signature of the cortex, as well as changes in the composition of NPCs, cortical lamination and glial cells [79]. In the prenatal CNS, microglia most robustly express receptors responsive to MIA-related immune factors, including receptors for IL-6 and IL-17 which have been causally linked to MIA and its neurobehavioral phenotypes [11, 12, 68]. In the fetal mouse brain, MIA was found to activate the integrated stress response (ISR) leading to an overall reduction in protein synthesis in cortical neuronal cell types and behavioural phenotype in males specifically [80]. This mechanism was found to be dependent on IL-17a signalling, suggesting that microglia are responsible for mediating this effect [80]. In line with this study, the MIA-induced transcriptomic changes in neuronal cell types could be reduced when genetically ablating microglia in Csf1r null mouse [68], although the absence of microglia in itself likely has an effect on the cortical transcriptome.
In the prenatal brain, microglia preferentially cluster at the highly neurogenic zones of the VZ/SVZ and were demonstrated to phagocytose NPCs [20]. Modulating microglial activation through MIA decreases the number of NPCs, while minocycline administration or microglial depletion increased the number of NPCs, without affecting proliferation, consistent with increased phagocytosis of NPCs by microglia following MIA [20]. MIA was also shown to lead to a decrease in the total number of PV interneurons in male rats [77]. Other studies also found a decrease in PV interneurons after MIA [81,82,83], as well as selective dysfunction of PV interneuron GABAergic transmission projecting onto the pyramidal cells in the mPFC in adult offspring [82]. Optogenetically silencing PV interneurons is able to recapitulate the anxiety-like behaviour seen after MIA [82]. To examine the role of microglia in the dysfunctional PV interneuron network following MIA, it was demonstrated that the decreased inhibitory drive from PV interneurons in adults (P60) can been seen after both MIA and upon microglial depletion using CSF1R inhibition [84]. Surprisingly, there was an initial increase in the inhibitory drive in juveniles at postnatal day 20 (P20), which might reflect improper development of the PV interneurons [84]. Using a different approach, it has been shown how MIA results in downregulation of expression of GPR56 in fetal microglia, through maternal IL-17a signalling [85]. Deletion of GPR56 in mice inhibits the proliferation of neural progenitors committed to forming PV interneurons and mimics the decreased number of PV interneurons and behavioural phenotype seen after MIA. Restoring GPR56 expression after MIA was able to partly rescue PV interneuron deficits and autism-like behaviour in mice at P21 [85]. In another study looking at the hippocampus of adult offspring following MIA exposure, found that minocycline treatment (P21-P56), a known inhibitor of microglia, was able to reverse the behavioural deficits, neuroinflammation, microglial ‘activation’ and the decrease in PV interneurons, as well as rescue the MIA induced functional alterations of PV interneuron activity and GABAergic transmission [86]. Increasing microglial expression of arginase 1 (ARG1), which is involved in regulating microglia activation and neuroinflammation, was able to ameliorate MIA-induced behavioural- and PV interneuron deficits, whereas ablation of microglial ARG1 expression prevented the protective effects of minocycline treatment [86]. Overall, modulating microglia functioning seems to recapitulate the MIA induced deficits in the PV interneuron network. In vitro data shows how an induced pluripotent stem cell (iPSC) derived co-culture of activated microglia and developmental cortical interneurons results in disruptions of interneuron metabolic pathways, arborization and synapse formation, with persistent metabolic dysregulation in the SCZ-derived cortical interneurons but not healthy controls [87]. In summary, there is evidence supporting that the effect of MIA on the cortical neuronal cell types, including PV interneurons, may be at least partially mediated through microglia.
MIA-induced effects on the synaptic level
Microglia are also involved in regulating the formation of neural connectivity on the level of individual synapses, and alterations in the densities of synapses have been observed in offspring following MIA induction. Especially during adolescence and early adulthood there is extensive elimination of supernumerary synapses, a process in which microglia are intricately involved through synaptic ‘pruning’, a process dependent on neural activity and the complement system [23, 24]. In 1982, Feinberg already postulated that alterations in synaptic composition due to dysregulated synaptic pruning might underly NDDs like SCZ, which is now referred to as the ‘synaptic hypothesis’ [88, 89]. Meta-analyses of post-mortem studies looking at the brains of SCZ patients found decreased pre-synaptic and post-synaptic markers, suggestive of alterations in synaptic densities that are supported by electron microscopy studies [89]. A post-mortem study of the brains from individuals aged 4 to 22 years old with ASD found that the expression of genes involved in synaptic function, GABAergic signalling, axon guidance, and neuronal migration were dysregulated and coincided with ASD annotated risk genes [90]. Specifically, microglia demonstrated enrichment in genes associated with activation, as well as transcriptional factors implicated in developmental processes, which exhibited correlations with clinical severity [90]. Still, post-mortem studies can be subject to confounding factors like the use of medication, lifestyle, brain region investigated, and disease state at time of a donors death. Additional evidence suggesting disrupted synaptic pruning in neurodevelopmental disorders (NDDs) involves genetic variations in complement component 4 (C4), which is part of a complement protein cascade tagging synapses for elimination by microglia. Genetic variations of C4 have been strongly linked with an increased risk for SCZ, and an increased expression of C4 has been found in the brain of SCZ patients [91]. Differential gene expression analysis of the fetal rat brain shortly after MIA showed changes in expression of genes related to neurogenesis, axonal guidance and synaptogenesis [92]. Possibly, MIA can perturb microglial-dependent synaptic pruning and affect proper neural network maturation.
Animal studies report MIA-induced alterations in microglial-synaptic contacting, dysregulated pruning and changes in synaptic densities in offspring. Using their motile processes, microglia frequently contact synapses in an activity-dependent manner [52, 53] and can remodel synaptic connections accordingly [24]. In acutely isolated brain slices from MIA-induced mice, alterations were found in the process motility of fetal and adult microglia [93]. Changes in microglial process motility could be also be observed in non-MIA-exposed brain slices through IL-6 stimulation [93]. Additionally, MIA exposure results in an increased expression of microglial genes related to synaptogenesis, neuronal cell adhesion/filopodia formation, and an increase in microglial interactions with excitatory pre-synaptic structures, enhanced filopodia formation and spine density in layer V at P60, as well as changes in their neurophysiological properties [94]. This suggests that MIA induces changes in microglial-synaptic interactions and/or pruning. Microglial repopulation using CSF1R inhibition could ameliorate the behavioural phenotype and reverse the increase in microglial-neuronal interactions [94].
MIA results in increased synaptic densities, possibly through inhibition of microglial-neural interactions. After MIA induction, the spinal density of granule cells in the hippocampus was increased at P15, a critical period for synaptic pruning, but only in male mice [95]. In parallel, there was a male-specific decrease in the expression of CX3CR1 on the mRNA [95] and protein level [96]. CX3CR1 is primarily expressed by microglia in the CNS and knockout of CX3CR1, a mediator in microglial-neural interactions and synaptic pruning, results in a transient increase in spinal density as well as ASD-like behavioural deficits [23, 25]. Possibly, reduced microglial expression of CX3CR1 is limiting microglia-neural interactions and, consequently, inhibiting synaptic pruning ultimately leading to the increase in synaptic density seen early in postnatal life. Chamera et al., 2020 also noted changes in the mRNA and protein expression of the CX3CL1-CX3CR1 and CD200-CD200R pathways in the hippocampus and cortex following MIA, depending on the use of LPS or Poly I:C, but neither immunostimulant affected the co-localization of CX3CL1-CX3CR1 and CD200-CD200R at P7 [97].
In contrast, other studies demonstrate how MIA results in decreased synaptic densities. After MIA, activation of microglia was seen alongside decreased protein levels of pre- and post-synaptic makers and ultrastructural changes in the cortex of adult (P52-P54) rats [98]. In mice, MIA resulted in a decrease in pre-synaptic density in the hippocampus and dentate gyrus, observed only in adult mice [99]. When looking at the post-synaptic density, a decrease in was noted both in pubescent and adult mice [99]. In the cortex of adult rat offspring, MIA resulted in an increased neuro-inflammatory profile, as measured by an increase in the expression of inflammatory cytokines, and co-localization of Il-1β with microglia, and a decrease in pre-synaptic vesicles and synaptic density [98]. In a different MIA model, a combination of air pollutants and resource deprivation was used to induce stress in mice resulting in a maternal pro-inflammatory response similar to the Poly and I:C model [100]. On top of the aberrant social behaviour in male offspring, gene expression analysis showed how most differentially expressed genes were enriched in microglia, including synapse genes [100]. When examining the thalamicocortical circuits, this MIA model resulted in an initial male-specific overgrowth of synapses at P8, followed by a reduction in thalamicocortical connections at P15 persistent at adulthood [100]. Compared to no stress exposure, microglia in MIA-induced mice offspring were found to engulf less synapses and were less phagocytic at P10 [100]. Another study also found a decrease in dendritic spine density and less extensive dendritic branches in adulthood in the granule cells of the dentate gyrus and layer II/III pyramidal mPFC neurons [101]. A SCZ patient-derived co-culture of microglia and synaptosomes revealed that SCZ-derived microglia displayed a higher uptake of synaptic material compared healthy control derived microglia, demonstrating a link with SCZ genetic risk to altered synaptic pruning [102]. In summary, there is strong evidence demonstrating that MIA causes alterations in synaptic/spine densities and microglial-synapse interactions, suggesting dysfunctional microglia-dependent synaptic pruning. This is further supported by studies demonstrating that microglial repopulation using CSF1R inhibition can ameliorate MIA-induced effects on spine densities and their electrophysiological properties [94]. Interestingly, there is evidence pointing towards a time-dependent effect of MIA, with studies showing an initial increase in synaptic densities early in post-natal life followed by a decrease in synaptic density in the adult brain consistent with post-mortem findings in human SCZ patients [89, 103]. However, whether these changes are truly time-dependent remains elusive since several other studies report opposite results in synaptic densities at similar timings, although these findings might be brain region dependent [104].
MIA-induced reprogramming of microglia and a possible role for epigenetics
One of the questions that remains is how stimulation of microglia in the fetal brain can have such long-lasting consequences. Microglia have a slow turnover compared to other hematopoietic cells and have a long lifespan that can extend to more than 20 years [105], and so early life-programming can potentially have persistent and adverse effects later in postnatal life. Indeed, MIA has been shown to cause changes in the microglial transcriptome that persist into adulthood in the offspring, although the effect seems relatively small [68, 78]. A recent fate-tracing study investigated the dynamics of DAM-like microglia using a model of stroke and resolution in neonatal (P6) and juvenile (P30) mice [106]. The authors found that DAM-like microglia induced by stroke in neonatal mice were able to regain their homeostatic phenotype following stroke resolution [106]. In contrast, when stroke was induced in juveniles, nearly all DAM-like microglia were eliminated while the few remaining cells maintained their DAM-like phenotype [106]. This demonstrates that at earlier developmental time-points, activated microglia can reintegrate back into the CNS parenchyma as seemingly homeostatic microglia. However, when re-exposed to an immune trigger (LPS), the reintegrated ‘homeostatic’ microglia show an enhanced inflammatory response [106]. This altered response to a secondary immune stimulus is reminiscent of innate immune memory as observed in adult animals [107, 108]. This is consistent with MIA models, where prenatal immune exposure similarly leads to an ‘innate immune memory’ and an altered inflammatory response by microglia in postnatal life [75, 109]. However, instead of an enhanced immune response, LPS re-exposure in adulthood results in a diminished inflammatory response, as measured by a decrease in microglial expression of pro-inflammatory cytokines, in whole brain of mice [75]. There was a region-specific increased inflammatory response in the hippocampus [75]. In line with the previous study, a diminished microglial immune response was also found in the frontal cortex and striatum, as measured by the downregulation of genes involved in immune pathways, microglial morphology and lysosomal content [109]. These results point towards microglia undergoing ‘immune tolerance’ when exposed to immune activation in prenatal life, although this effect shows brain region-specific changes since hippocampal microglia results in ‘immune training’. Another study found that exposure to peripubertal stress following fetal MIA exposure acted synergistically in activating hippocampal microglia as measured by CD68 and CD11b staining and increased levels of pro-inflammatory cytokines in the hippocampus of mice [110].
Overall, these studies indicate that effect of early life reprogramming of microglia can have significant functional consequences later in life. These can be unmasked upon restimulation, with signs of immune tolerance or training depending on the timing and mode of activation. Immune training or tolerance has already been shown to influence the development of neuropathology in animal models of Alzheimer's disease and stroke [107], as well as influence cognitive function in adults [75], demonstrating that immune priming of microglia can have a significant biological effect [107]. In a model for neurodevelopment, exposure to immune stress might act as a second hit for immune ‘primed’ microglia early in life, a phenomenon highly relevant for SCZ since manifestation of clinical symptoms typically occurs later in young adult life (Fig. 2). Microglial reprogramming results in an altered inflammatory response to immune stress which may disrupt CNS homeostasis. This is in line with studies showing a beneficial effect of minocycline, a drug that inhibits microglia, in MIA animal models [78, 111, 112] as well in patients with SCZ [113]. Alternatively, innate immune memory in fetal microglia may directly interfere with neurodevelopmental processes that require microglia and immune signalling (Fig. 2). For example, microglial-dependent synaptic pruning is highly reliant on the complement system [114].
It is currently not yet clear what constitutes the molecular mechanisms underlying the persistent change in the microglial transcriptome and the altered immune response in microglia following MIA. Epigenetic regulation in microglia, as observed innate immune memory, presents a potential candidate mechanism to explain the lasting effects of MIA. Similar to peripheral myeloid cells, microglia are capable of developing an innate immune memory through epigenetic programming [107, 115]. In a MIA mouse model, it has been demonstrated that the blunted immune response in adulthood was associated with changes in the microglial epigenetic landscape after LPS re-exposure, with more open-chromatin regions but less transcription factors occupying these regions [109]. A MIA mouse model of maternal allergic asthma also induces fetal neuroinflammation [116] and results in microglial-specific epigenetic changes, including sites associated with inflammatory genes overlapping with ASD risk annotated genes [117]. Immune activation early in postnatal life was also shown to change the microglial epigenetic landscape at gene promoter regions, and there was evidence suggestive of enhanced synaptic pruning and reduced dendritic spines, specifically in males [118] (Fig. 2). We propose that MIA exposure similarly reprograms the epigenetic signature of microglia in the fetal brain, leading to persistent changes in the microglial transcriptome and inflammatory response seen in postnatal life (Fig. 2). Intriguingly, repopulation of microglia using CSF1R inhibition has been successful in reversing MIA induced phenotypes [94, 109]. Following CSF1R inhibition, repopulation of the microglial cell pool comes from local self-renewal and is not dependent on the contribution of non-microglial cells [119]. On the transcriptomic level, initially these newborn microglia go from a ‘neonatal’ stage and gradually become more similar to adult [120]. On top of ameliorating the blunted immune response, repopulation of MIA-induced microglia did not show distinct clustering from control microglia (i.e. non-MIA and without CSF1R inhibition) [109]. Perhaps, these newly born microglia start without any pre-existing transcriptomic or epigenetic biases imprinted on them during development as a result from environmental disturbances such as MIA. In the future, it would be interesting to continue investigating microglial dynamics using CSF1R inhibition, especially in relation to changes in their epigenetic signature. For example, it is currently unclear whether the few surviving microglia following CSF1R inhibition are predetermined and if so, if this subpopulation of microglia has unique functional characteristics which are propagated to newborn cells after self-renewal. Conversely, if the surviving microglia following CSF1R inhibition are not unique, does the process of self-renewal initiate a transcriptomic reset, possibly through an epigenetic wipe, and thereby re-establishing the normal microglial transcriptomic and functional state. Further research is required to determine whether epigenetic mechanisms are responsible for the altered immune response following MIA induction.
Conclusions
Currently it is not clear whether immune activation of microglia acts as the mediator driving the increased risk of NDDs when exposed to MIA. There is evidence, consisting mostly of animal studies, suggesting direct involvement of microglia in the MIA-induced effects observed at the neuronal-, particularly the PV interneurons, and synaptic level, both of which are strongly associated with the neuropathology of NDDs. There is also evidence that MIA has long-lasting functional consequences on the microglial inflammatory response, suggesting that neurodevelopmental- and/or CNS homeostatic processes requiring microglia and immune signalling are potentially compromised. How these effects are related to MIA induced NND-like behaviour, and ultimately how this translates to humans, remains to be understood. In order to better understand the role of microglia in relation MIA and NDDs, it is important to more comprehensively map the involvement of microglia in normal neurodevelopment. Recently, scRNA-seq and other transcriptomic studies revealed increased microglial heterogeneity during fetal brain development, identifying unique microglial subsets, hinting at functionally distinct roles. The appearance of DAM-like microglia, which were originally associated with neurodegenerative conditions, at different stages of development is particularly interesting since their phenotype suggests that these microglia are highly engaged. In the future, new tools such as spatial transcriptomics and high-plex spatial proteomics (i.e. imaging mass cytometry) can enhance our understanding of microglial heterogeneity in relation to other CNS cell types. This will enable us to map microglial-cell interactions at a single-cell level, providing deeper insight into their specific functional roles during neurodevelopment, and study alterations when exposed to MIA.
Data availability
No original data was generated for this review article.
References
Han VX, Patel S, Jones HF, Dale RC (2021) Maternal immune activation and neuroinflammation in human neurodevelopmental disorders. Nat Rev Neurol 17:564–579
Jiang H, Xu L, Shao L et al (2016) Maternal infection during pregnancy and risk of autism spectrum disorders: A systematic review and meta-analysis. Brain Behav Immun 58:165–172. https://doi.org/10.1016/j.bbi.2016.06.005
Brown AS, Patterson PH (2011) Maternal Infection and Schizophrenia: Implications for Prevention. Schizophr Bull 37:284–290. https://doi.org/10.1093/schbul/sbq146
Khandaker GM, Zimbron J, Lewis G, Jones PB (2013) Prenatal maternal infection, neurodevelopment and adult schizophrenia: a systematic review of population-based studies. Psychol Med 43:239–257. https://doi.org/10.1017/S0033291712000736
Solek CM, Farooqi N, Verly M et al (2018). Maternal Immune Activation in Neurodevelopmental Disorders. https://doi.org/10.1002/dvdy
Seker A, Qirko-Gurakuqi A, Tabaku M et al (2023) Maternal atopic conditions and autism spectrum disorder: a systematic review. Eur Child Adolesc Psychiatry. https://doi.org/10.1007/s00787-023-02285-7
Chen S, Zhong X, Jiang L et al (2016) Maternal autoimmune diseases and the risk of autism spectrum disorders in offspring: A systematic review and meta-analysis. Behav Brain Res 296:61–69. https://doi.org/10.1016/j.bbr.2015.08.035
Bilbo SD, Block CL, Bolton JL et al (2018) Beyond infection - Maternal immune activation by environmental factors, microglial development, and relevance for autism spectrum disorders. Exp Neurol 299:241–251
Haddad FL, Patel SV, Schmid S (2020) Maternal Immune Activation by Poly I: C as a preclinical Model for Neurodevelopmental Disorders: A focus on Autism and Schizophrenia. Neurosci Biobehav Rev 113:546–567
Brown AS (2012) Epidemiologic studies of exposure to prenatal infection and risk of schizophrenia and autism. Dev Neurobiol 72:1272–1276. https://doi.org/10.1002/dneu.22024
Smith SEP, Li J, Garbett K et al (2007) Maternal immune activation alters fetal brain development through interleukin-6. J Neurosci 27:10695–10702. https://doi.org/10.1523/JNEUROSCI.2178-07.2007
Choi GB, Yim YS, Wong H et al (1979) (2016) The maternal interleukin-17a pathway in mice promotes autism-like phenotypes in offspring. Science 351:933–939. https://doi.org/10.1126/science.aad0314
Hickman SE, Kingery ND, Ohsumi TK et al (2013) The microglial sensome revealed by direct RNA sequencing. Nat Neurosci 16:1896–1905. https://doi.org/10.1038/nn.3554
Swinnen N, Smolders S, Avila A et al (2013) Complex invasion pattern of the cerebral cortex bymicroglial cells during development of the mouse embryo. Glia 61:150–163. https://doi.org/10.1002/glia.22421
Nimmerjahn A, Kirchhoff F (1979) Helmchen F (2005) Resting Microglial Cells Are Highly Dynamic Surveillants of Brain Parenchyma in Vivo. Science 308:1314–1318. https://doi.org/10.1126/science.1110647
Dubbelaar ML, Kracht L, Eggen BJL, Boddeke EWGM (2018) The Kaleidoscope of Microglial Phenotypes. Front Immunol 9
Borst K, Dumas AA, Prinz M (2021) Microglia: Immune and non-immune functions. Immunity 54:2194–2208. https://doi.org/10.1016/j.immuni.2021.09.014
Rodríguez-Gómez JA, Kavanagh E, Engskog-Vlachos P, et al (2020) Microglia: Agents of the CNS Pro-Inflammatory Response. Cells 9:. https://doi.org/10.3390/cells9071717
Arnò B, Grassivaro F, Rossi C, et al (2014) Neural progenitor cells orchestrate microglia migration and positioning into the developing cortex. Nat Commun 5:. https://doi.org/10.1038/ncomms6611
Cunningham CL, Martínez-Cerdeño V, Noctor SC (2013) Microglia regulate the number of neural precursor cells in the developing cerebral cortex. J Neurosci 33:4216–4233. https://doi.org/10.1523/JNEUROSCI.3441-12.2013
Barger N, Keiter J, Kreutz A et al (2019) Microglia: An Intrinsic Component of the Proliferative Zones in the Fetal Rhesus Monkey (Macaca mulatta) Cerebral Cortex. Cereb Cortex 29:2782–2796. https://doi.org/10.1093/cercor/bhy145
Squarzoni P, Oller G, Hoeffel G et al (2014) Microglia Modulate Wiring of the Embryonic Forebrain. Cell Rep 8:1271–1279. https://doi.org/10.1016/j.celrep.2014.07.042
Paolicelli RC, Bolasco G, Pagani F et al (1979) (2011) Synaptic Pruning by Microglia Is Necessary for Normal Brain Development. Science 333:1456–1458. https://doi.org/10.1126/science.1202529
Schafer DP, Lehrman EK, Kautzman AG et al (2012) Microglia Sculpt Postnatal Neural Circuits in an Activity and Complement-Dependent Manner. Neuron 74:691–705. https://doi.org/10.1016/j.neuron.2012.03.026
Gunner G, Cheadle L, Johnson KM et al (2019) Sensory lesioning induces microglial synapse elimination via ADAM10 and fractalkine signaling. Nat Neurosci 22:1075–1088. https://doi.org/10.1038/s41593-019-0419-y
Lawrence AR, Canzi A, Bridlance C et al (2024) Microglia maintain structural integrity during fetal brain morphogenesis. Cell. https://doi.org/10.1016/j.cell.2024.01.012
Kracht L, Borggrewe M, Eskandar S et al (1979) (2020) Human fetal microglia acquire homeostatic immune-sensing properties early in development. Science 369:530–537. https://doi.org/10.1126/science.aba5906
Bergdolt L, Dunaevsky A (2019) Brain changes in a maternal immune activation model of neurodevelopmental brain disorders. Prog Neurobiol 175:1–19. https://doi.org/10.1016/j.pneurobio.2018.12.002
Santos-Silva T, dos Santos FD, de Oliveira CL et al (2023) Prefrontal and Hippocampal Parvalbumin Interneurons in Animal Models for Schizophrenia: A Systematic Review and Meta-analysis. Schizophr Bull. https://doi.org/10.1093/schbul/sbad123
Holst CB, Brøchner CB, Vitting-Seerup K, Møllgård K (2019) Astrogliogenesis in human fetal brain: complex spatiotemporal immunoreactivity patterns of GFAP, S100, AQP4 and YKL-40. J Anat 235:590–615. https://doi.org/10.1111/joa.12948
Jakovcevski I (2009) Oligodendrocyte development and the onset of myelination in the human fetal brain. Front Neuroanat 3:. https://doi.org/10.3389/neuro.05.005.2009
Ginhoux F, Greter M, Leboeuf M et al (1979) (2010) Fate Mapping Analysis Reveals That Adult Microglia Derive from Primitive Macrophages. Science 330:841–845. https://doi.org/10.1126/science.1194637
Oosterhof N, Chang IJ, Karimiani EG et al (2019) Homozygous Mutations in CSF1R Cause a Pediatric-Onset Leukoencephalopathy and Can Result in Congenital Absence of Microglia. The American Journal of Human Genetics 104:936–947. https://doi.org/10.1016/j.ajhg.2019.03.010
Verney C, Monier A, Fallet-Bianco C, Gressens P (2010) Early microglial colonization of the human forebrain and possible involvement in periventricular white-matter injury of preterm infants. J Anat 217:436–448. https://doi.org/10.1111/j.1469-7580.2010.01245.x
Menassa DA, Gomez-Nicola D (2018) Microglial dynamics during human brain development. Front Immunol 9
Barry-Carroll L, Gomez-Nicola D (2024) The molecular determinants of microglial developmental dynamics. Nat Rev Neurosci
Silvin A, Qian J, Ginhoux F (2023) Brain macrophage development, diversity and dysregulation in health and disease. Cell Mol Immunol 20:1277–1289. https://doi.org/10.1038/s41423-023-01053-6
Ferent J, Zaidi D, Francis F (2020) Extracellular Control of Radial Glia Proliferation and Scaffolding During Cortical Development and Pathology. Front Cell Dev Biol 8:. https://doi.org/10.3389/fcell.2020.578341
Peri F, Nüsslein-Volhard C (2008) Live Imaging of Neuronal Degradation by Microglia Reveals a Role for v0-ATPase a1 in Phagosomal Fusion In Vivo. Cell 133:916–927. https://doi.org/10.1016/j.cell.2008.04.037
Kamei R, Okabe S (2023) In vivo imaging of the phagocytic dynamics underlying efficient clearance of adult-born hippocampal granule cells by ramified microglia. Glia 71:2005–2023. https://doi.org/10.1002/glia.24379
Noctor SC, Penna E, Shepherd H et al (2019) Periventricular microglial cells interact with dividing precursor cells in the nonhuman primate and rodent prenatal cerebral cortex. Journal of Comparative Neurology 527:1598–1609. https://doi.org/10.1002/cne.24604
Marı́n-Teva JL, Dusart I, Colin C, et al (2004) Microglia Promote the Death of Developing Purkinje Cells. Neuron 41:535–547. https://doi.org/10.1016/S0896-6273(04)00069-8
Hattori Y, Miyata T (2018) Microglia extensively survey the developing cortex via the CXCL12/CXCR4 system to help neural progenitors to acquire differentiated properties. Genes Cells 23:915–922. https://doi.org/10.1111/gtc.12632
Aarum J, Sandberg K, Budd Haeberlein SL, Persson MAA (2003) Migration and differentiation of neural precursor cells can be directed by microglia
Shigemoto-Mogami Y, Hoshikawa K, Goldman JE et al (2014) Microglia enhance neurogenesis and oligodendrogenesis in the early postnatal subventricular zone. J Neurosci 34:2231–2243. https://doi.org/10.1523/JNEUROSCI.1619-13.2014
Jahangir M, Zhou J-S, Lang B, Wang X-P (2021) GABAergic System Dysfunction and Challenges in Schizophrenia Research. Front Cell Dev Biol 9:663854. https://doi.org/10.3389/fcell.2021.663854
Pont-Lezica L, Beumer W, Colasse S et al (2014) Microglia shape corpus callosum axon tract fasciculation: functional impact of prenatal inflammation. Eur J Neurosci 39:1551–1557. https://doi.org/10.1111/ejn.12508
Hammond TR, Robinton D, Stevens B (2018). Annual Review of Cell and Developmental Biology Microglia and the Brain: Complementary Partners in Development and Disease. https://doi.org/10.1146/annurev-cellbio-100616
Sierra A, Encinas JM, Deudero JJP et al (2010) Microglia Shape Adult Hippocampal Neurogenesis through Apoptosis-Coupled Phagocytosis. Cell Stem Cell 7:483–495. https://doi.org/10.1016/j.stem.2010.08.014
Nemes-Baran AD, White DR, DeSilva TM (2020) Fractalkine-Dependent Microglial Pruning of Viable Oligodendrocyte Progenitor Cells Regulates Myelination. Cell Rep 32:108047. https://doi.org/10.1016/j.celrep.2020.108047
Wlodarczyk A, Holtman IR, Krueger M, et al (2017) A novel microglial subset plays a key role in myelinogenesis in developing brain. EMBO J 36:3292–3308. https://doi.org/10.15252/embj.201696056
Wake H, Moorhouse AJ, Jinno S et al (2009) Resting Microglia Directly Monitor the Functional State of Synapses In Vivo and Determine the Fate of Ischemic Terminals. J Neurosci 29:3974–3980. https://doi.org/10.1523/JNEUROSCI.4363-08.2009
Tremblay M-È, Lowery RL, Majewska AK (2010) Microglial Interactions with Synapses Are Modulated by Visual Experience. PLoS Biol 8:e1000527. https://doi.org/10.1371/journal.pbio.1000527
Favuzzi E, Huang S, Saldi GA et al (2021) GABA-receptive microglia selectively sculpt developing inhibitory circuits. Cell 184:4048-4063.e32. https://doi.org/10.1016/j.cell.2021.06.018
Vainchtein ID, Chin G, Cho FS et al (1979) (2018) Astrocyte-derived interleukin-33 promotes microglial synapse engulfment and neural circuit development. Science 359:1269–1273. https://doi.org/10.1126/science.aal3589
Weinhard L, Di Bartolomei G, Bolasco G, et al (2018) Microglia remodel synapses by presynaptic trogocytosis and spine head filopodia induction. Nat Commun 9:. https://doi.org/10.1038/s41467-018-03566-5
Miyamoto A, Wake H, Ishikawa AW et al (2016) Microglia contact induces synapse formation in developing somatosensory cortex. Nat Commun 7:12540. https://doi.org/10.1038/ncomms12540
Parkhurst CN, Yang G, Ninan I et al (2013) Microglia Promote Learning-Dependent Synapse Formation through Brain-Derived Neurotrophic Factor. Cell 155:1596–1609. https://doi.org/10.1016/j.cell.2013.11.030
Li Y, Li Z, Yang M et al (2022) Decoding the temporal and regional specification of microglia in the developing human brain. Cell Stem Cell 29:620-634.e6. https://doi.org/10.1016/j.stem.2022.02.004
Rosin JM, Sinha S, Biernaskie J, Kurrasch DM (2021) A subpopulation of embryonic microglia respond to maternal stress and influence nearby neural progenitors. Dev Cell 56:1326-1345.e6. https://doi.org/10.1016/j.devcel.2021.03.018
Han CZ, Li RZ, Hansen E et al (2023) Human microglia maturation is underpinned by specific gene regulatory networks. Immunity 56:2152-2171.e13. https://doi.org/10.1016/j.immuni.2023.07.016
Beiter RM, Sheehan PW, Schafer DP (2024) Microglia phagocytic mechanisms: Development informing disease. Curr Opin Neurobiol 86:102877. https://doi.org/10.1016/j.conb.2024.102877
Hammond TR, Dufort C, Dissing-Olesen L et al (2019) Single-Cell RNA Sequencing of Microglia throughout the Mouse Lifespan and in the Injured Brain Reveals Complex Cell-State Changes. Immunity 50:253-271.e6. https://doi.org/10.1016/j.immuni.2018.11.004
Li Q, Cheng Z, Zhou L et al (2019) Developmental Heterogeneity of Microglia and Brain Myeloid Cells Revealed by Deep Single-Cell RNA Sequencing. Neuron 101:207-223.e10. https://doi.org/10.1016/j.neuron.2018.12.006
Paolicelli RC, Sierra A, Stevens B et al (2022) Microglia states and nomenclature: A field at its crossroads. Neuron 110:3458–3483
Matcovitch-Natan O, Winter DR, Giladi A, et al (2016) Microglia development follows a stepwise program to regulate brain homeostasis. Science (1979) 353:. https://doi.org/10.1126/science.aad8670
Hanamsagar R, Alter MD, Block CS et al (2017) Generation of a microglial developmental index in mice and in humans reveals a sex difference in maturation and immune reactivity. Glia 65:1504–1520. https://doi.org/10.1002/glia.23176
LaMonica Ostrem BE, Domínguez-Iturza N, Stogsdill JA, et al (2024) Fetal brain response to maternal inflammation requires microglia. Development 151:. https://doi.org/10.1242/dev.202252
Estes ML (1979) McAllister AK (2016) Maternal immune activation: Implications for neuropsychiatric disorders. Science 353:772–777
Pasciuto E, Burton OT, Roca CP et al (2020) Microglia Require CD4 T Cells to Complete the Fetal-to-Adult Transition. Cell 182:625-640.e24. https://doi.org/10.1016/j.cell.2020.06.026
Meyer U (2014) Prenatal Poly(I:C) Exposure and Other Developmental Immune Activation Models in Rodent Systems. Biol Psychiatry 75:307–315. https://doi.org/10.1016/j.biopsych.2013.07.011
Meyer U, Nyffeler M, Engler A et al (2006) The Time of Prenatal Immune Challenge Determines the Specificity of Inflammation-Mediated Brain and Behavioral Pathology. J Neurosci 26:4752–4762. https://doi.org/10.1523/JNEUROSCI.0099-06.2006
Ardalan M, Chumak T, Vexler Z, Mallard C (2019) Sex-dependent effects of perinatal inflammation on the brain: Implication for neuro-psychiatric disorders. Int J Mol Sci 20:. https://doi.org/10.3390/ijms20092270
Smolders S, Notter T, Smolders SMT et al (2018) Controversies and prospects about microglia in maternal immune activation models for neurodevelopmental disorders. Brain Behav Immun 73:51–65
Schaafsma W, Basterra LB, Jacobs S et al (2017) Maternal inflammation induces immune activation of fetal microglia and leads to disrupted microglia immune responses, behavior, and learning performance in adulthood. Neurobiol Dis 106:291–300. https://doi.org/10.1016/j.nbd.2017.07.017
O’Loughlin E, Pakan JMP, Yilmazer-Hanke D, McDermott KW (2017) Acute in utero exposure to lipopolysaccharide induces inflammation in the pre- and postnatal brain and alters the glial cytoarchitecture in the developing amygdala. J Neuroinflammation 14:212. https://doi.org/10.1186/s12974-017-0981-8
Loayza M, Lin S, Carter K et al (2023) Maternal immune activation alters fetal and neonatal microglia phenotype and disrupts neurogenesis in mice. Pediatr Res 93:1216–1225. https://doi.org/10.1038/s41390-022-02239-w
Mattei D, Ivanov A, Ferrai C, et al (2017) Maternal immune activation results in complex microglial transcriptome signature in the adult offspring that is reversed by minocycline treatment. Transl Psychiatry 7:. https://doi.org/10.1038/tp.2017.80
Canales CP, Estes ML, Cichewicz K, et al (2021) Sequential perturbations to mouse corticogenesis following in utero maternal immune activation. Elife 10:. https://doi.org/10.7554/eLife.60100
Kalish BT, Kim E, Finander B et al (2021) Maternal immune activation in mice disrupts proteostasis in the fetal brain. Nat Neurosci 24:204–213. https://doi.org/10.1038/s41593-020-00762-9
Shin Yim Y, Park A, Berrios J et al (2017) Reversing behavioural abnormalities in mice exposed to maternal inflammation. Nature 549:482–487. https://doi.org/10.1038/nature23909
Canetta S, Bolkan S, Padilla-Coreano N et al (2016) Maternal immune activation leads to selective functional deficits in offspring parvalbumin interneurons. Mol Psychiatry 21:956–968. https://doi.org/10.1038/mp.2015.222
Vojtechova I, Maleninska K, Kutna V et al (2021) Behavioral Alterations and Decreased Number of Parvalbumin-Positive Interneurons in Wistar Rats after Maternal Immune Activation by Lipopolysaccharide: Sex Matters. Int J Mol Sci 22:3274. https://doi.org/10.3390/ijms22063274
Thion MS, Mosser CA, Férézou I et al (2019) Biphasic Impact of Prenatal Inflammation and Macrophage Depletion on the Wiring of Neocortical Inhibitory Circuits. Cell Rep 28:1119-1126.e4. https://doi.org/10.1016/j.celrep.2019.06.086
Yu D, Li T, Delpech J-C, et al (2022) Microglial GPR56 is the molecular target of maternal immune activation-induced parvalbumin-positive interneuron deficits
Xia Y, Zhang Z, Lin W et al (2020) Modulating microglia activation prevents maternal immune activation induced schizophrenia-relevant behavior phenotypes via arginase 1 in the dentate gyrus. Neuropsychopharmacology 45:1896–1908. https://doi.org/10.1038/s41386-020-0743-7
Park GH, Noh H, Shao Z et al (2020) Activated microglia cause metabolic disruptions in developmental cortical interneurons that persist in interneurons from individuals with schizophrenia. Nat Neurosci 23:1352–1364. https://doi.org/10.1038/s41593-020-00724-1
Feinberg I (1982) Schizophrenia: Caused by a fault in programmed synaptic elimination during adolescence? J Psychiatr Res 17:319–334. https://doi.org/10.1016/0022-3956(82)90038-3
Howes OD, Onwordi EC (2023) The synaptic hypothesis of schizophrenia version III: a master mechanism. Mol Psychiatry 28:1843–1856. https://doi.org/10.1038/s41380-023-02043-w
Velmeshev D, Schirmer L, Jung D et al (1979) (2019) Single-cell genomics identifies cell type–specific molecular changes in autism. Science 364:685–689. https://doi.org/10.1126/science.aav8130
Sekar A, Bialas AR, de Rivera H et al (2016) Schizophrenia risk from complex variation of complement component 4. Nature 530:177–183. https://doi.org/10.1038/nature16549
Lombardo MV, Moon HM, Su J et al (2018) Maternal immune activation dysregulation of the fetal brain transcriptome and relevance to the pathophysiology of autism spectrum disorder. Mol Psychiatry 23:1001–1013. https://doi.org/10.1038/mp.2017.15
Ozaki K, Kato D, Ikegami A, et al (2020) Maternal immune activation induces sustained changes in fetal microglia motility. Sci Rep 10:. https://doi.org/10.1038/s41598-020-78294-2
Ikezu S, Yeh H, Delpech JC et al (2021) Inhibition of colony stimulating factor 1 receptor corrects maternal inflammation-induced microglial and synaptic dysfunction and behavioral abnormalities. Mol Psychiatry 26:1808–1831. https://doi.org/10.1038/s41380-020-0671-2
Fernández de Cossío L, Guzmán A, van der Veldt S, Luheshi GN (2017) Prenatal infection leads to ASD-like behavior and altered synaptic pruning in the mouse offspring. Brain Behav Immun 63:88–98. https://doi.org/10.1016/j.bbi.2016.09.028
Fernández de Cossío L, Lacabanne C, Bordeleau M et al (2021) Lipopolysaccharide-induced maternal immune activation modulates microglial CX3CR1 protein expression and morphological phenotype in the hippocampus and dentate gyrus, resulting in cognitive inflexibility during late adolescence. Brain Behav Immun 97:440–454. https://doi.org/10.1016/j.bbi.2021.07.025
Chamera K, Kotarska K, Szuster-Głuszczak M, et al (2020) The prenatal challenge with lipopolysaccharide and polyinosinic:polycytidylic acid disrupts CX3CL1-CX3CR1 and CD200-CD200R signalling in the brains of male rat offspring: A link to schizophrenia-like behaviours. J Neuroinflammation 17:. https://doi.org/10.1186/s12974-020-01923-0
Cieślik M, Gąssowska-Dobrowolska M, Jęśko H et al (2020) Maternal Immune Activation Induces Neuroinflammation and Cortical Synaptic Deficits in the Adolescent Rat Offspring. Int J Mol Sci 21:4097. https://doi.org/10.3390/ijms21114097
Giovanoli S, Weber-Stadlbauer U, Schedlowski M et al (2016) Prenatal immune activation causes hippocampal synaptic deficits in the absence of overt microglia anomalies. Brain Behav Immun 55:25–38. https://doi.org/10.1016/j.bbi.2015.09.015
Block CL, Eroglu O, Mague SD, et al (2022) Prenatal environmental stressors impair postnatal microglia function and adult behavior in males. Cell Rep 40:. https://doi.org/10.1016/j.celrep.2022.111161
Li WY, Chang YC, Lee LJH, Lee LJ (2014) Prenatal infection affects the neuronal architecture and cognitive function in adult mice. Dev Neurosci 36:359–370. https://doi.org/10.1159/000362383
Sellgren CM, Gracias J, Watmuff B et al (2019) Increased synapse elimination by microglia in schizophrenia patient-derived models of synaptic pruning. Nat Neurosci 22:374–385. https://doi.org/10.1038/s41593-018-0334-7
Lin Y-L, Wang S (2014) Prenatal lipopolysaccharide exposure increases depression-like behaviors and reduces hippocampal neurogenesis in adult rats. Behav Brain Res 259:24–34. https://doi.org/10.1016/j.bbr.2013.10.034
Pekala M, Doliwa M, Kalita K (2021) Impact of maternal immune activation on dendritic spine development. Dev Neurobiol 81:524–545. https://doi.org/10.1002/dneu.22804
Réu P, Khosravi A, Bernard S et al (2017) The Lifespan and Turnover of Microglia in the Human Brain. Cell Rep 20:779–784. https://doi.org/10.1016/j.celrep.2017.07.004
Lan Y, Zhang X, Liu S et al (2024) Fate mapping of Spp1 expression reveals age-dependent plasticity of disease-associated microglia-like cells after brain injury. Immunity 57:349-363.e9. https://doi.org/10.1016/j.immuni.2024.01.008
Wendeln A-C, Degenhardt K, Kaurani L et al (2018) Innate immune memory in the brain shapes neurological disease hallmarks. Nature 556:332–338. https://doi.org/10.1038/s41586-018-0023-4
Zhang X, Kracht L, Lerario AM, et al (2022) Epigenetic regulation of innate immune memory in microglia. J Neuroinflammation 19:. https://doi.org/10.1186/s12974-022-02463-5
Hayes LN, An K, Carloni E et al (2022) Prenatal immune stress blunts microglia reactivity, impairing neurocircuitry. Nature 610:327–334. https://doi.org/10.1038/s41586-022-05274-z
Giovanoli S, Engler H, Engler A et al (2013) Stress in puberty unmasks latent neuropathological consequences of prenatal immune activation. Science 1979:339
Giovanoli S, Engler H, Engler A, et al (2016) Preventive effects of minocycline in a neurodevelopmental two-hit model with relevance to schizophrenia. Transl Psychiatry 6:. https://doi.org/10.1038/tp.2016.38
Zhu F, Zheng Y, Liu Y et al (2014) Minocycline alleviates behavioral deficits and inhibits microglial activation in the offspring of pregnant mice after administration of polyriboinosinic–polyribocytidilic acid. Psychiatry Res 219:680–686. https://doi.org/10.1016/j.psychres.2014.06.046
Solmi M, Veronese N, Thapa N et al (2017) Systematic review and meta-analysis of the efficacy and safety of minocycline in schizophrenia. CNS Spectr 22:415–426. https://doi.org/10.1017/S1092852916000638
Soteros BM, Sia GM (2022) Complement and microglia dependent synapse elimination in brain development. WIREs mechanisms of disease 14:e1545. https://doi.org/10.1002/wsbm.1545
Neher JJ, Cunningham C (2019) Priming Microglia for Innate Immune Memory in the Brain. Trends Immunol 40:358–374. https://doi.org/10.1016/j.it.2019.02.001
Tamayo JM, Rose D, Church JS et al (2022) Maternal Allergic Asthma Induces Prenatal Neuroinflammation. Brain Sci 12:1041. https://doi.org/10.3390/brainsci12081041
Vogel Ciernia A, Careaga M, LaSalle JM, Ashwood P (2018) Microglia from offspring of dams with allergic asthma exhibit epigenomic alterations in genes dysregulated in autism. Glia 66:505–521. https://doi.org/10.1002/glia.23261
Schwabenland M, Mossad O, Sievert A, et al (2023) Neonatal immune challenge poses a sex-specific risk for epigenetic microglial reprogramming and behavioral impairment. Nat Commun 14:. https://doi.org/10.1038/s41467-023-38373-0
Huang Y, Xu Z, Xiong S et al (2018) Repopulated microglia are solely derived from the proliferation of residual microglia after acute depletion. Nat Neurosci 21:530–540. https://doi.org/10.1038/s41593-018-0090-8
Zhan L, Krabbe G, Du F, et al (2019) Proximal recolonization by self-renewing microglia re-establishes microglial homeostasis in the adult mouse brain. PLoS Biol 17:. https://doi.org/10.1371/journal.pbio.3000134
Artwork and Illustrations
Adobe Illustrator 2024 was used for creating the figures used in this review.
Funding
This work was supported by ZonMw (Netherlands Organisation for Health Research and Development) Grant 09032212110019 (J.R. Prins).
Author information
Authors and Affiliations
Contributions
L.J.M. Mastenbroek, S.M. Kooistra, and J.R. Prins conceptualized the manuscript. L.J.M. Mastenbroek wrote the manuscript., S.M. Kooistra, B.J.L. Eggen and J.R. Prins provided critical feedback on the manuscript. All authors read and approved the final manuscript.
Corresponding author
Ethics declarations
Competing Interests
The authors have no relevant financial or non-financial interests to disclose.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Mastenbroek, L.J.M., Kooistra, S.M., Eggen, B.J.L. et al. The role of microglia in early neurodevelopment and the effects of maternal immune activation. Semin Immunopathol 46, 1 (2024). https://doi.org/10.1007/s00281-024-01017-6
Received:
Accepted:
Published:
DOI: https://doi.org/10.1007/s00281-024-01017-6